KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 62 filers reported holding KITE PHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $88,035,000 | +487.4% | 489,605 | +238.7% | 0.03% | +420.0% |
| Q2 2017 | $14,987,000 | -29.2% | 144,566 | -46.4% | 0.01% | +66.7% |
| Q1 2017 | $21,162,000 | +66.1% | 269,580 | -5.2% | 0.00% | +50.0% |
| Q4 2016 | $12,744,000 | +578.2% | 284,252 | +745.2% | 0.00% | +100.0% |
| Q3 2016 | $1,879,000 | +91.9% | 33,633 | +71.7% | 0.00% | – |
| Q2 2016 | $979,000 | -6.0% | 19,583 | -13.6% | 0.00% | – |
| Q1 2016 | $1,041,000 | -21.8% | 22,674 | +4.8% | 0.00% | – |
| Q4 2015 | $1,332,000 | +14.5% | 21,628 | +3.5% | 0.00% | – |
| Q3 2015 | $1,163,000 | -42.4% | 20,889 | -37.0% | 0.00% | -100.0% |
| Q2 2015 | $2,020,000 | -35.0% | 33,138 | -38.5% | 0.00% | 0.0% |
| Q1 2015 | $3,106,000 | +102.3% | 53,841 | +102.3% | 0.00% | 0.0% |
| Q4 2014 | $1,535,000 | +141.4% | 26,610 | +19.3% | 0.00% | – |
| Q3 2014 | $636,000 | – | 22,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|